Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A headline-grabbing lawsuit shines a light on pregnancy rights, workplace duties, and the real financial stakes of wo...
Emergence AI ran five 15-day simulations using leading AI agents to test how autonomous systems could govern a synthe...
NVIDIA’s AI surge is redefining the memory supply chain, and Micron investors face new headwinds. This deep dive expl...
Nio just hit a landmark: a swapped million batteries week. The feat showcases its battery-swapping edge, but does it ...
The quantum computing sector has faced a pullback, but not every hire is a misfire. This article breaks down the rece...
Investors confront a familiar fork: cash out a top-performing rental to ease debt on another, or hold for long-term g...
If you could pick just one tech stock to own, which name would you choose? This in-depth look explains why a single p...
Quantum tech is moving from dream to data. This article explores Rigetti Computing, its revenue path, risks, and a pr...
Billionaire Bill Ackman recently shifted gears, selling a former cornerstone stake to fund two AI stock bets. This mo...
Investors weighing a gold-only ETF versus a silver-backed ETF face a tradeoff: gold offers lower volatility and costs...
Smart, patient investors are weighing Ford in a way that goes beyond the headline numbers. Here are two durable reaso...